TimesSquare Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
TimesSquare Capital Management's RGEN Position: Q1 2026 in Review
TimesSquare Capital Management increased its Repligen (RGEN) stake by 4.7% in Q1 2026, buying an estimated $2.85M and bringing the position to 456,083 shares worth $53.7M. The position accounts for 0.91% of the portfolio, ranked #36.
TimesSquare Capital Management first reported a position in RGEN in Q3 2016 and has held it in 22 quarters since. The position peaked at $97.9M in Q2 2017. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- TimesSquare Capital Management held 456,083 shares of Repligen worth $53.7M as of Q1 2026.
- TimesSquare Capital Management bought 20,396 Repligen shares in Q1 2026, an estimated $2.85M.
- Repligen made up 0.91% of TimesSquare Capital Management's portfolio in Q1 2026, its #36 holding.
- TimesSquare Capital Management first reported a position in Repligen in Q3 2016 and has held it in 22 quarters since.
- TimesSquare Capital Management's Repligen position peaked at $97.9M in Q2 2017.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on TimesSquare Capital Management's 13F filing for Q1 2026, filed 7 May 2026.